In Nigeria, the prevalence of vitamin A deficiency among under-fives was estimated at about 30 percent in 2018. High dose vitamin A supplementation (VAS) can reduce all-cause under-five mortality by 24 percent, yet its A proportion (%) that reflects the number of people receiving (an) intervention(s) divided by the total number of people eligible to receive the intervention(s) remains low in Nigeria at 45 percent. Seasonal malaria chemoprevention (SMC) presents a viable platform to increase vitamin A coverage among under-fives as it achieves high administrative coverage. We carried out a study to test the The sharing of all or specific campaign components or functions by a specific program addressing a disease or health need with the broader health system and ongoing delivery of int of VAS with SMC campaigns in Bauchi state.
Download the learning brief here.